Published in J Natl Cancer Inst on December 06, 2000
Study of Metformin With Simvastatin for Men With Prostate Carcinoma | NCT01561482
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst (2011) 2.85
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79
A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights (2007) 2.39
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer (2009) 1.90
Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer (2003) 1.87
Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer (2009) 1.74
Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT. Cancer Res (2011) 1.71
HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924. Mol Cancer Ther (2008) 1.40
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34
Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst (2009) 1.27
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet (2010) 1.18
Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Cancer Res (2008) 1.16
Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut (2011) 1.13
Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab (2013) 1.11
Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys (2008) 1.08
Cancer cell signaling pathways targeted by spice-derived nutraceuticals. Nutr Cancer (2011) 1.07
Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder. World J Gastroenterol (2011) 1.03
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. Cancer Res (2008) 1.01
Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium. Virchows Arch (2003) 1.00
Targeting the insulin-like growth factor-1 receptor in human cancer. Front Pharmacol (2013) 1.00
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate (2008) 1.00
Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer (2003) 1.00
Insulin-like growth factor-I and prostate cancer: a meta-analysis. Br J Cancer (2001) 0.99
Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer. Cancer Causes Control (2010) 0.98
Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. J Cancer Res Clin Oncol (2014) 0.95
Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender. Ann Epidemiol (2009) 0.95
IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol Pathol (2001) 0.94
Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br J Cancer (2003) 0.92
Silymarin and epithelial cancer chemoprevention: how close we are to bedside? Toxicol Appl Pharmacol (2006) 0.91
Zinc and cancer: implications for LIV-1 in breast cancer. Nutrients (2012) 0.91
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prev Res (Phila) (2013) 0.90
Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system. Pediatr Nephrol (2004) 0.89
Metabolic imbalance and prostate cancer progression. Int J Mol Epidemiol Genet (2010) 0.89
Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J Nutr (2009) 0.88
Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites. J Natl Med Assoc (2007) 0.87
Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions. Am J Transl Res (2009) 0.87
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability. Mol Cancer (2010) 0.87
Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer. Int J Cancer (2014) 0.87
Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men. J Natl Med Assoc (2009) 0.86
Are strict vegetarians protected against prostate cancer? Am J Clin Nutr (2015) 0.86
A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res (2016) 0.86
Complementary and alternative medicines in prostate cancer: from bench to bedside? Oncologist (2012) 0.85
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy. Front Oncol (2015) 0.85
Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels. Br J Cancer (2008) 0.84
Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat. Endocrinology (2007) 0.84
Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing. J Oncol Pract (2011) 0.84
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis. Cancer Causes Control (2017) 0.84
Weight control and cancer preventive mechanisms: role of insulin growth factor-1-mediated signaling pathways. Exp Biol Med (Maywood) (2013) 0.83
NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation. Cancer Res (2009) 0.83
Occupational physical activity and risk for prostate cancer in a nationwide cohort study in Sweden. Br J Cancer (2002) 0.82
Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study. Mol Carcinog (2009) 0.82
The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond) (2012) 0.81
Male reproductive health and prostate cancer risk. Curr Opin Urol (2011) 0.81
Examining the relationship between obesity and prostate cancer. Rev Urol (2004) 0.81
Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer. Front Endocrinol (Lausanne) (2013) 0.80
Pleiotropy between genetic markers of obesity and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.78
Serum glucose and risk of cancer: a meta-analysis. BMC Cancer (2014) 0.78
Prostate cancer, insulin, and androgen deprivation therapy. Br J Cancer (2003) 0.78
Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants. Int J Pediatr (2013) 0.78
Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. Int J Cancer (2015) 0.77
Cancer. Adv Exp Med Biol (2005) 0.77
Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model. J Endocrinol (2011) 0.77
Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis. Mol Clin Oncol (2015) 0.76
Association of gastric cancer with tyrosine hydroxylase gene polymorphism in a northwestern Chinese population. Clin Exp Med (2007) 0.76
Re: plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2001) 0.75
IGF-IR and its inhibitors in gastrointestinal carcinomas (Review). Oncol Lett (2010) 0.75
Plasma-free amino acid profiles are predictors of cancer and diabetes development. Nutr Diabetes (2017) 0.75
The ovarian cancer oncobiome. Oncotarget (2017) 0.75
Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells. Biochem Biophys Rep (2016) 0.75
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med (1999) 2.79
Comparison of nutrients in the food composition tables available in the nine European countries participating in EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (1999) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol (1999) 2.58
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr (2001) 2.37
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis (2005) 2.35
Bispectral Index compared to Ramsay score for sedation monitoring in intensive care units. Minerva Anestesiol (2006) 2.35
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology (1997) 2.29
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol (2000) 2.28
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia (2007) 2.23
Validation and calibration of dietary intake measurements in the EPIC project: methodological considerations. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 2.23
European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr (2002) 2.23
The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment Pharmacol Ther (2011) 2.12
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer (2004) 2.05
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03
Probable case of vascular air embolism during endonasal CO2 laser surgery. Minerva Anestesiol (2009) 2.02
Serum carotenoids and breast cancer. Am J Epidemiol (2001) 2.02
Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst (1992) 2.01
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. Aliment Pharmacol Ther (2014) 2.00
Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia (2013) 1.93
Standardization of the 24-hour diet recall calibration method used in the european prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary results. Eur J Clin Nutr (2000) 1.92
Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol (2005) 1.88
Consumption of meat, animal products, protein, and fat and risk of breast cancer: a prospective cohort study in New York. Epidemiology (1994) 1.82
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. European Prospective Investigation into Cancer and Nutrition. Comput Methods Programs Biomed (1999) 1.68
Meat consumption and colorectal cancer: a review of epidemiologic evidence. Nutr Rev (2001) 1.68
Calorie-providing nutrients and risk of breast cancer. J Natl Cancer Inst (1989) 1.67
Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination with a discriminatory serum hCG level of 1000 IU/l (IRP) Br J Obstet Gynaecol (1990) 1.65
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63
Radioimmunoassay of plasma renin activity. Clin Chem (1976) 1.62
Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med (1997) 1.61
Low folate levels may protect against colorectal cancer. Gut (2006) 1.60
Silent thalassemias: genotypes and phenotypes. Haematologica (1997) 1.60
Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 1.58
Weight change in later life and risk of death amongst the elderly: the European Prospective Investigation into Cancer and Nutrition-Elderly Network on Ageing and Health study. J Intern Med (2010) 1.58
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer (1986) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54
Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr (2002) 1.53
Normal early pregnancy: serum hCG levels and vaginal ultrasonography findings. Br J Obstet Gynaecol (1990) 1.53
Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer (1999) 1.52
Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum. Clin Chem (1999) 1.52
Leptin is associated with increased risk of myocardial infarction. J Intern Med (1999) 1.52
Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 1.51
Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol (1993) 1.51
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene (2011) 1.50
Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr (2009) 1.49
Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2006) 1.47
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Invest (2001) 1.47
Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction. Scand J Clin Lab Invest (2004) 1.47
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology (2015) 1.47